Allianca Saude e Participacoes SA - ALLIAR(BR:AALR3)
R$0.95-0.36 (-27.48%)
BR:AALR3
Allianca Saude e Participacoes SA - ALLIAR financials statements
R$0.95
At close:-0.36 (-27.48%)
Allianca Saude e Participacoes SA - ALLIAR (AALR3) Ratios
Allianca Saude e Participacoes SA - ALLIAR Ratios
BR:AALR3's free cash flow for Q4 2025 was R$-123.10M. For the 2025 fiscal year, BR:AALR3's free cash flow was decreased by R$-38.78M and operating cash flow was R$-84.32M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.28 | 1.04 | 0.71 | 0.71 | 0.83 |
| Quick Ratio | 0.28 | 1.02 | 0.70 | 0.69 | 0.81 |
| Cash Ratio | 0.07 | 0.17 | 0.30 | 0.32 | 0.22 |
| Solvency Ratio | -0.62 | -0.02 | -0.07 | -0.07 | 0.09 |
| Operating Cash Flow Ratio | 0.06 | -0.06 | 0.14 | 0.28 | 0.25 |
| Short-Term Operating Cash Flow Coverage | 0.20 | -0.14 | 0.27 | 0.44 | 0.41 |
| Net Current Asset Value | R$ -1.52B | R$ -1.06B | R$ -1.20B | R$ -1.15B | R$ -843.51M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.33 | 0.49 | 0.51 | 0.42 |
| Debt-to-Equity Ratio | -2.51 | 0.87 | 1.43 | 1.41 | 0.91 |
| Debt-to-Capital Ratio | 1.66 | 0.46 | 0.59 | 0.58 | 0.48 |
| Long-Term Debt-to-Capital Ratio | -0.02 | 0.28 | 0.42 | 0.39 | 0.26 |
| Financial Leverage Ratio | -6.40 | 2.64 | 2.91 | 2.75 | 2.16 |
| Debt Service Coverage Ratio | -0.04 | 0.36 | 0.22 | 0.15 | 0.45 |
| Interest Coverage Ratio | -0.22 | 0.60 | 0.16 | -0.18 | 0.91 |
| Debt to Market Cap | 0.66 | 0.71 | 1.04 | 0.42 | 0.44 |
| Interest Debt Per Share | 6.13 | 9.55 | 13.16 | 12.83 | 9.88 |
| Net Debt to EBITDA | 10.68 | 4.53 | 7.05 | 14.96 | 4.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.01% | 29.22% | 30.93% | 30.02% | 31.33% |
| EBIT Margin | -4.59% | 6.77% | 3.51% | -3.97% | 7.63% |
| EBITDA Margin | 4.71% | 15.17% | 13.12% | 6.88% | 18.17% |
| Operating Profit Margin | -4.59% | 8.80% | 3.30% | -2.95% | 7.23% |
| Pretax Profit Margin | -110.55% | -7.84% | -16.91% | -21.50% | 0.22% |
| Net Profit Margin | -118.94% | -10.61% | -19.32% | -21.00% | -0.49% |
| Continuous Operations Profit Margin | -117.85% | -9.14% | -18.53% | -20.21% | 0.17% |
| Net Income Per EBT | 107.59% | 135.27% | 114.24% | 97.67% | -229.03% |
| EBT Per EBIT | 2408.19% | -89.16% | -512.76% | 728.01% | 2.99% |
| Return on Assets (ROA) | -77.21% | -4.47% | -8.54% | -8.71% | -0.22% |
| Return on Equity (ROE) | 494.46% | -11.79% | -24.84% | -23.99% | -0.48% |
| Return on Capital Employed (ROCE) | 582.19% | 4.82% | 2.01% | -1.65% | 4.21% |
| Return on Invested Capital (ROIC) | -10.74% | 4.23% | 1.66% | -1.26% | 2.83% |
| Return on Tangible Assets | -91.57% | -6.85% | -13.66% | -14.01% | -0.37% |
| Earnings Yield | -178.36% | -12.77% | -22.66% | -9.16% | -0.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.12 | 2.62 | 5.83 | 4.75 | 3.66 |
| Payables Turnover | 3.89 | 9.18 | 6.32 | 8.06 | 10.35 |
| Inventory Turnover | 103.57 | 74.14 | 66.45 | 51.89 | 67.11 |
| Fixed Asset Turnover | 1.47 | 1.51 | 1.48 | 1.34 | 1.43 |
| Asset Turnover | 0.65 | 0.42 | 0.44 | 0.41 | 0.45 |
| Working Capital Turnover Ratio | -1.84 | -13.37 | -5.84 | -7.37 | -291.77 |
| Cash Conversion Cycle | -1.59 | 104.23 | 10.32 | 38.62 | 69.78 |
| Days of Sales Outstanding | 88.60 | 139.06 | 62.55 | 76.86 | 99.60 |
| Days of Inventory Outstanding | 3.52 | 4.92 | 5.49 | 7.03 | 5.44 |
| Days of Payables Outstanding | 93.71 | 39.75 | 57.72 | 45.27 | 35.26 |
| Operating Cycle | 92.12 | 143.98 | 68.05 | 83.89 | 105.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.67 | -0.35 | 0.86 | 1.59 | 1.27 |
| Free Cash Flow Per Share | 0.16 | -1.19 | 0.09 | 0.63 | 0.41 |
| Dividend Paid and CapEx Coverage Ratio | 1.08 | -0.41 | 0.96 | 1.63 | 1.45 |
| Capital Expenditure Coverage Ratio | 1.31 | -0.41 | 1.12 | 1.66 | 1.48 |
| Operating Cash Flow Coverage Ratio | 0.15 | -0.04 | 0.08 | 0.14 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.09 | -0.03 | 0.09 | 0.17 | 0.13 |
| Free Cash Flow Yield | 3.17% | -13.89% | 1.07% | 2.99% | 2.76% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.56 | -7.83 | -4.41 | -10.92 | -312.83 |
| Price-to-Sales (P/S) Ratio | 0.67 | 0.83 | 0.85 | 2.29 | 1.55 |
| Price-to-Book (P/B) Ratio | -2.77 | 0.92 | 1.10 | 2.62 | 1.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 31.59 | -7.20 | 93.24 | 33.49 | 36.18 |
| Price-to-Operating Cash Flow Ratio | 7.53 | -24.64 | 9.83 | 13.28 | 11.80 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.18 | 0.00 | -0.00 | 3.32 |
| Enterprise Value Multiple | 24.84 | 10.00 | 13.55 | 48.31 | 13.09 |
| Enterprise Value | 1.35B | 1.85B | 2.10B | 3.60B | 2.70B |
| EV to EBITDA | 24.84 | 10.00 | 13.55 | 48.31 | 13.09 |
| EV to Sales | 1.17 | 1.52 | 1.78 | 3.32 | 2.38 |
| EV to Free Cash Flow | 55.41 | -13.15 | 194.37 | 48.52 | 55.59 |
| EV to Operating Cash Flow | 13.21 | -45.03 | 20.49 | 19.25 | 18.13 |
| Tangible Book Value Per Share | -3.48 | 1.12 | -0.49 | -0.06 | 2.00 |
| Shareholders’ Equity Per Share | -1.82 | 9.26 | 7.76 | 8.06 | 10.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.07 | -0.17 | -0.10 | 0.06 | 0.19 |
| Revenue Per Share | 7.57 | 10.29 | 9.97 | 9.21 | 9.67 |
| Net Income Per Share | -9.01 | -1.09 | -1.93 | -1.93 | -0.05 |
| Tax Burden | 1.08 | 1.35 | 1.14 | 0.98 | -2.29 |
| Interest Burden | 24.08 | -1.16 | -4.82 | 5.41 | 0.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.25 | 0.20 | 0.28 | 0.31 | 0.23 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.08 | 0.35 | -0.47 | -0.85 | 75.01 |
Currency in BRL

